Preprint · OA
via OpenAlex
Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome
May-Yun Wang, Paul Arthur Grayburn, Shuyuan Chen, Mariella Ravazzola, Lelio Orci, Roger H. Unger
Proceedings of the National Academy of Sciences · 2008 · ▲ 144 citations
Abstract
To determine whether adipocyte storage capacity influences the onset and severity of type 2 diabetes and other components of the metabolic syndrome, we made normal and db/db mice resistant to obesity by overexpressing leptin receptor-b on the aP2-Lepr-b promoter. On a 4% diet, these mice have no phenotype, but on a 60% fat diet, they resist diet-induced obesity because constitutive adipocyte-specific overexpression of Lepr-b prevents obesity via the antilipogenic autocrine/paracrine action of leptin on adipocytes. After 8 months on the same 60% fat diet, body fat of transgenic mice was 70% below WT controls. Cardiac and liver fat was elevated in the transgenics, and their hyperinsulinemia was more marked, suggesting greater insulin resistance. The aP2-Lepr-b transgene also prevented obesity in db/db mice; at 10 weeks of age their body fat was half that of the db/db mice. This lack of obesity was attributable to reduced expression of sterol regulatory element binding protein-1c and its target lipogenic enzymes in adipose tissue and a 6-fold increase in Pref-1 mRNA. Severe diabetes was present in transgenics at 4 weeks of age, 10 weeks before db/db controls. Echocardiographic evidence of cardiomyopathy appeared at 10 weeks, weeks before the db/db mice. Histologically, loss of beta cells and myocardial fibrosis was present in the transgenic group at least 6 weeks before the db/db mice. These results suggest that the expression level of genes that regulate the adipogenic response to overnutrition profoundly influences the age of onset and severity of diet-induced type 2 diabetes and co-morbidities.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1073/pnas.0801981105
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Wang, M., Grayburn, P.A., Chen, S., Ravazzola, M., Orci, L., & Unger, R.H. (2008). Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome. <em>Proceedings of the National Academy of Sciences</em>. https://doi.org/10.1073/pnas.0801981105
Vancouver
Wang M, Grayburn PA, Chen S, Ravazzola M, Orci L, Unger RH. Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome. Proceedings of the National Academy of Sciences. 2008. doi:10.1073/pnas.0801981105.
BibTeX
@unpublished{mayyun2008Adipog,
title = {Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome},
author = {May-Yun Wang and Paul Arthur Grayburn and Shuyuan Chen and Mariella Ravazzola and Lelio Orci and Roger H. Unger},
journal = {Proceedings of the National Academy of Sciences},
year = {2008},
doi = {10.1073/pnas.0801981105},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cardiology Clinics 2004
Citation only
Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications
Metabolism 2006
Preprint · CC-BY
Effects of lifestyle modification on metabolic parameters and carotid intima-media thickness in patients with type 2 diabetes mellitus
Journal of Endocrinological Investigation 2008
Citation only
Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome
Journal of Biological Rhythms 2017
Open access · CC-BY
The Association between Social Jetlag, the Metabolic Syndrome, and Type 2 Diabetes Mellitus in the General Population: The New Hoorn Study
PubMed 2009
Preprint
Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Diabetes Care 2011
Open access · CC-BY